Want to see IONM full AI Analyst Report?
Top Page
Rating:―N/A
Price Target:―
Action:N/A
Date:―
No summary available
Positive Factors
Service Demand
The demand for intraoperative neuromonitoring services is likely to remain stable or grow, as these services are crucial for patient safety during surgeries involving the nervous system.
Negative Factors
Financial Instability
Negative equity and high debt levels indicate financial instability, limiting the company's ability to invest in growth and potentially leading to solvency issues.
Read all positive and negative factors
Positive Factors
Negative Factors
Service Demand
The demand for intraoperative neuromonitoring services is likely to remain stable or grow, as these services are crucial for patient safety during surgeries involving the nervous system.
Read all positive factors
Assure Holdings (IONM) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.84K
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)-29513.43
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees95
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,674,492
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-1.28
Price to Sales (P/S)76.98
P/FCF Ratio-3.89
Enterprise Value/Market Cap7.99K
Enterprise Value/Revenue168.78
Enterprise Value/Gross Profit-8.69
Enterprise Value/Ebitda-0.72
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Assure Holdings Business Overview & Revenue Model
Company Description
Assure Holdings Corp., through its various subsidiaries, specializes in delivering expert technical and professional support for intraoperative neuromonitoring (IONM), predominantly during complex spine and cranial surgical procedures. The company...
How the Company Makes Money
Assure Holdings generates revenue primarily by providing intraoperative neuromonitoring services to hospitals and surgical centers. The company employs technologists who work in the operating room and neurologists who monitor the procedures remote...
Assure Holdings Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Dec 2023 | Mar 2023 | Dec 2021 | Dec 2020 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 87.00K | 255.00K | 471.00K | 29.19M | 3.52M | 17.73M |
| Gross Profit | -1.69M | -2.19M | -2.07M | 14.87M | -4.39M | 12.77M |
| EBITDA | -20.35M | -19.21M | -20.02M | -1.39M | -14.48M | 4.31M |
| Net Income | -20.52M | -26.08M | -30.11M | -2.76M | -15.04M | 2.72M |
Balance Sheet | ||||||
| Total Assets | 5.28M | 7.51M | 24.25M | 48.41M | 33.64M | 44.38M |
| Cash, Cash Equivalents and Short-Term Investments | 45.00K | 123.00K | 905.00K | 4.02M | 4.39M | 59.00K |
| Total Debt | 15.60M | 14.80M | 14.35M | 15.87M | 7.64M | 6.21M |
| Total Liabilities | 23.92M | 22.85M | 18.78M | 19.45M | 14.43M | 34.49M |
| Stockholders Equity | -18.64M | -15.34M | 5.46M | 28.96M | 19.21M | 9.89M |
Cash Flow | ||||||
| Free Cash Flow | -3.43M | -5.04M | -8.11M | -12.94M | -2.85M | -4.28M |
| Operating Cash Flow | -3.43M | -5.04M | -8.03M | -13.37M | -2.53M | -4.23M |
| Investing Cash Flow | 1.86M | -471.00K | -280.00K | 1.00K | -7.50M | 465.00K |
| Financing Cash Flow | -1.55M | 4.73M | 4.30M | 13.01M | 14.36M | 2.99M |
Assure Holdings Technical Analysis
Positive
4.20
Price Trends
0.22
Positive
0.13
Positive
Market Momentum
0.59
Negative
100.00
Negative
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IONM, the sentiment is Positive. The current price of 4.2 is above the 20-day moving average (MA) of 0.47, above the 50-day MA of 0.22, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.59 indicates Negative momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IONM.
Assure Holdings Risk Analysis
Assure Holdings disclosed 53 risk factors in its most recent earnings report. Assure Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Assure Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | $1.84K | ― | ― | ― | ― | ― | |
61 Neutral | $80.20M | -0.29 | 184.97% | ― | -0.87% | 10.51% | |
50 Neutral | $10.00M | -6.71 | -8.75% | ― | -0.62% | -200.79% | |
49 Neutral | $19.58M | -0.03 | ― | ― | 20.26% | 69.68% | |
44 Neutral | $54.03M | -0.29 | -88.97% | ― | -42.03% | -28904.55% |
* Healthcare Sector Average
IONM
Assure Holdings
4.20
4.17
14382.76%
AMS
American Shared Hospital Services
1.51
-0.98
-39.36%
CCM
Concord Medical Services
4.51
-1.29
-22.24%
DCGO
DocGo
0.55
-1.03
-65.38%
PIII
P3 Health Partners
11.07
4.69
73.51%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―